Health CareHealth Care Equipment & Services

  • Price (GBX)36.80
  • Todays Change-0.20 / -0.54%
  • Shares traded5.50k
  • 1 Year change+13.23%
  • Beta1.5149

Data delayed at least 20 minutes, as of Aug 31 2021 08:49 BST.

More ▼

Forecasts data is unavailable for this security.

  • 17-Sep-20
  • 17-Jun-21
  • 15-Jul-21
  • 19-Aug-21
  • 26-Aug-21

Select bar for recommendation details.

Recommendations26-Aug-21
Buy0
Outperform1
Hold0
Underperform0
Sell0

The 2 analysts offering 12 month price targets for Advanced Oncotherapy PLC have a median target of 117.50, with a high estimate of 135.00 and a low estimate of 100.00. The median estimate represents a 217.57% increase from the last price of 37.00.

High264.9%135.00
Med217.6%117.50
Low170.3%100.00
Advanced Oncotherapy PLC reported annual 2020 losses of -8.75 per share on Jun 30, 2021.
Average growth rate+14.51%

More ▼

Refinitiv, an LSEG business

Refinitiv

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not real time. Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Say hello

Find us at the office

Chappa- Adamitis street no. 38, 81811 Tripoli, Libya

Give us a ring

Alda Runion
+69 213 130 910
Mon - Fri, 10:00-22:00

Say hello